Circulating 14-day erythroid progenitors (BFU-E) from 28 sickle cell anemia (SS) patients with hemoglobin F (HbF) levels ranging from 2% to 16% were studied to determine their sensitivity to [3H] thymidine kill and burst-promoting activity (BPA)-like factor production. We find that the proportion of BFU-E sensitive to 3H-dT kill, and hence active in DNA synthesis, was inversely correlated with the percent of peripheral HbF when light density (LD) mononuclear cells were used for plating. Regression analysis showed that the correlation between HbF level and BFU-E kill was highly significant ( r = .88; P -= .oooO3). We confirmed the BPA-like factor(s) production by LD mononu-E HAVE PREVIOUSLY reported that the number W of circulating burst-forming units of the erythroid line (BFU-E) is inversely correlated with the circulating hemoglobin F (HbF) levels in sickle cell anemia (SS) patients and that circulating erythroid progenitors have increased sensitivity to erythropoietin due, a t least partially, to the constitutive production of burst-promoting activity (BPA)-like factor(s) by light density mononuclear cells (LD cells).' The data also indicated a relationship between the constitutive HbF expression, the number of circulating BFU-E, and the modification of BFU-E kinetics due to BPA-like factor(s) production. ' The increased number of circulating BFU-E in SS patients with low HbF levels may reflect changes in BFU-E regulation in one or a combination of the following ways: (1) increased cycling of circulating BFU-E (normally quiescent or in long G,), which leads to the increased number of circulating BFU-E; (2) triggering of early bone marrow BFU-E or even less mature progenitors (CFU-MIX) to enter the cell cycle, resulting in amplification of bone marrow BFU-E compartments and subsequent release of erythroid stem cells into the circulation; and/or (3) increased exit of bone marrow BFU-E into the circulation without changes in proportion of BFU-E in the cell cycle.
different peripheral HbF levels. In the studies reported here, we are able to show that an increased number of circulating BFU-E in SS patients with low HbF levels is associated with an increased proportion of circulating BFU-E in active DNA synthesis. We find that peripheral HbF levels correlate inversely with the proportion of BFU-E engaged in DNA synthesis and the level of BPA-like factor activity generated by LD cells.
MATERIALS AND METHODS

Patient material. Samples from a pool of 28 SS patients were obtained from the Comprehensive Sickle Cell Center of the Albert Einstein College of Medicine (Bronx, NY). Their clinical laboratory
parameters and CY and /3 haplotype status are shown in Table I . Ages ranged from 19 to 64 years, and 14 were females and 14 were males. Normal volunteers were obtained from hospital personnel. "Low" and "high" HbF groups are very similar in age, sex, creatinine, and alpha thalassemia. In the low HbF group, there is a small increase in the number of dense cells, and a lower Hb level was accompanied by a higher reticulocyte count, higher total bilirubin, and higher lactate dehydrogenase (LDH) level. The high HbF group had an excess of patients with at least one chromosome of the Senegal type @-gene cluster haplotype). When the samples were not part of normal medical care, informed consent was obtained before venipuncture.
Mononuclear cells were separated from 20 to 30 mL of heparinized peripheral blood by 30 minutes centrifugation at 400g in Ficoll-Hypaque (density, 1.077 g/mL; Pharmacia Fine Chemicals AB, Uppsala, Sweden). The cells from the interface were washed twice with alpha medium supplemented with 2% heat-inactivated fetal calf serum (FCS), enumerated, and then diluted with alpha medium to 3 x lo6 cells/mL. These cells were either immediately plated (6 x lo6 cells/mL) for suicide experiments or were used as a source of the LD nonadherent cell population and/or for preparation of conditioned medium.
The methylcellulose culture system used was described previously.' Briefly, nucleated cells (3 x lo5) were added to culture medium so that each milliliter contained a final concentration of 30% FCS, 10% of 10% stock BSA solution (albumin bovine fraction V), 10% mercaptoethanol mol/L final concentration), 10% of erythropoietin (E$; Toyobo, Osaka, Japan), 30% methylcellulose. The cells were plated in Multiwell tissue culture plates (0.5 mL per well) with a final concentration of 3
x IO5 cells/mL. The plates were incubated at 37OC in 5% CO, in air at 100% humidity. Colonies were counted at day 14 under a dissecting or inverted microscope.
In many instances our experiments were conducted at two EpO Peripheral blood LD cells separation.
Assay for 14-day BFU-E. concentrations (0.75, 1.5 and 3 U/mL) to assure that we were working in the plateau region of the dose-response curve. These concentrations correspond to saturating concentrations of EpO for SS and normal BFU-E, respectively.' Light density mononuclear cells conditioned medium (CM) were obtained as follows: LD cells (18 x IO6) were allowed to adhere to 60 x 15 mm tissue culture dishes in 3 mL of alpha medium with 2% FCS for 24 hours. At the end of incubation, the nonadherent cell suspension was removed and centrifuged, and the CM was harvested and saved for further use. The nonadherent cell pellets were resuspended in alpha medium with 2% FCS to a final concentration of 3 x IO6 cells/mL for plating in methylcellulose culture.
Twenty percent of fresh or frozen CM was added to the methylcellulose culture containing 0.75 U EpO/ mL and 3 x IO5 LD nonadherent autologous or heterologous cells.
At day 14 erythroid colonies were counted, and the stimulatory effect of CM was evaluated by comparison of the number of colonies generated in the presence of either 0.75 U EpO only or in the presence of EpO and CM. The stimulatory activity of CM is referred to as A activity and is calculated by subtracting the number of BFU-E with EpO from the number grown in the presence of EpO and CM.
To test the extent of adhesion obtained with this procedure we subjected several of these preparations to a second cycle of adhesion. No adherent cells were observed.
['HI thymidine ('H-TdR) suicide tests in vitro were performed according to the following procedure, modified from that described by Becker et al. ' Two aliquots of LD cell suspension (6 x lo6 cells/mL) were taken. One aliquot of each (1 mL) was placed in a separate tube and centrifuged. The pellets were then resuspended in the mixture containing 0.9 mL of alpha medium supplemented with 10% FCS, 0.1 mL of 100 pCi of 'H-TdR of high specific activity (20 Ci/mmol; New England Nuclear, Boston, MA), and 0.1 mL of equimolar doses (1.2 pg) of nonradioactive thymidine to match the concentration of nonradioactive thymidine in 'H-TdR preparation. The cells were incubated for 20 minutes at 37°C (5% CO, and 100% humidity), washed twice (first wash with 200 pg/mL of cold thymidine and second wash with 48 pg/mL), diluted, and plated in methyl cellulose culture in the presence of two different concentrations of EpO (1.5 U and 3 U of EpO/mL of culture medium). The erythroid colonies were counted at day 14, and the proportion of BFU-E engaged in DNA synthesis (BFU-E,) was calculated as follows: BFU-E, = [(x -y)/x] x 100, where x is the mean number of bursts per control culture treated with nonradioac-
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Suicide technique.
tive thymidine; y is the mean number of bursts per culture treated with radioactive thymidine. The percentage of BFU-E killed was derived from a ratio calculated from two means, each having its own variance. A relatively large number of experiments was therefore required for statistical ~alidity.~.' The proportion of 'H-TdR kill was established by comparing the means for the BFU-E number in the group treated with 'H-TdR versus the control group, according to the recommendations of Liestol and Benestad.'
A 1-minute alkali denaturation test was used to determine the percentage of peripheral HbF in hemolysates prepared from SS patients' red blood cells. Normals had an HbF level of less than 1%. For some of the analyses, SS patients are divided into two subpopulations according to the HbF levels. Patients with HbF levels lower than 9% were assigned to the low HbF group, while patients with HbF over 9% were classified in the high HbF group. The basis for this separation into percent HbF classes is presented in Fig 1 and discussed in the corresponding Results section.
Dense cells (SS4), a, and j 3 haplotypes were performed as reported previously.
Statistics. The data was analyzed with help of an IBM-AT, using the Lotus spreadsheet program. Distribution statistics, regresBlood HbF and other determinations. 
RESULTS
Correlation between HbF blood levels in SS patients and number of peripheral BFU-E per well. Regression analysis of the number of peripheral blood BFU-E and the level of HbF in 26 SS patients is depicted in Fig 1. The regression has an r of -.54 with a significance where P < .004. The dotted lines separate two fields of the regression. To the left of the vertical dotted line (at about 9% HbF), the points are all above the number of BFU-E found in normal individuals and there is considerable dispersion. To the right of the vertical dotted line the points are all a t normal BFU-E levels, except for one patient. For the purposes of this study, "high" HbF will refer to all patients with more than 9% HbF and "low" HbF, those with less than 9%.
Comparison of 'H-TdR suicide of BFU-E from fresh blood of SS patients with high and low HbF levels. The proportion of circulating BFU-E engaged in DNA synthesis from patients with high and low HbF levels was assessed by comparing LD cells exposed to high specific activity 'H-TdR with controls exposed to a matched dose of nonradioactive thymidine. The cells were then repeatedly washed and plated (at two cell concentrations) in methylcellulose cultures in the presence of 1.5 and 3 U EpO per mL for the assay of surviving BFU-E.
In Table 2 is represented a typical experiment with blood of an SS patient with high peripheral HbF level (12%): the number of 14-day erythroid progenitors are not as significantly modified by exposure to high specific activity 'H-TdR. These results are not affected by EpO concentrations used for culture stimulation or by the number of cells plated.
In contrast, 14-day erythroid progenitors of SS patients with low HbF levels (3%) were sensitive to 'H-TdR kill as shown by significant reduction of erythropoietic bursts resulting from exposure to cytotoxic agents. BFU-E kill percentage derived from these numbers indicates that approximately 40% of BFU-E are engaged in DNA synthesis.
SS patients' circulating BFU-E cycling is negatively correlated with peripheral HbF levels.
The proportion of circulating BFU-E engaged in DNA synthesis was determined in 16 SS patients (7 patients with H b F greater than 9% and 9 patients with HbF less than 9%; 3 patients were studied on two separate occasions, one patient with 3% HbF and two others with 12% and 13% HbF, respectively). The cycling of BFU-E was evaluated as described in Materials and Methods, and the final plating was done in a methylcellulose culture in the presence of two EpO concentrations (1.5 and 3 U per mL of culture media). Regression analysis performed on the percent of BFU-E kill in the group cultured in the presence of 1.5 U EpO/mL showed that the correlation between HbF level and BFU-E kill is highly significant, with a probability level of .00003 ( r = -.88, r2 = 77.7%); (Fig 2) . The fact that the same correlation can be demonstrated in the group cultured in the presence of 3 U/mL of EpO (r = -3 2 , P = .00032, r2 = 67.4%; data not shown) indicates that this phenomenon is not affected by EpO concentration, and hence the experiments were conducted a t a plateau in the EpO/BFU-E dose-response curve. Furthermore, repeated determinations in the same individual demonstrated that the BFU-E sensitivity to 'H-TdR remained constant over several months.
Comparison of BFU-E stimulatory factor production (BPA-like activity) by LD cells of SSpatients with high and low peripheral HbF levels. We evaluated the BPA-like factor production by LD cells of 20 SS patients with various levels of HbF (2% to 15.7%). LD nonadherent cells were plated in the absence or presence of 20% autologous C M (prepared as described in Materials and Methods) and 0.75 U of EpO. The results are expressed as the A number of colonies, defined as the difference between the number of erythroid colonies produced in the presence and absence of autologous CM. Despite interpatient variation (Fig 3) , the stimulatory activity was consistently detected in the C M produced by mononuclear cells from patients with HbF ranging from 2% to 8.8%, as seen from the fact that the A number of erythroid colonies generated in the presence of 20% autologous C M ranged from 17 to 93 erythroid colonies (Mean A = 46.4 f 24.9). Such activity was absent in the C M by mononuclear cells of patients with high HbF levels (from 9% to 15.7%). In these patients the addition of 20% autologous C M did not significantly increase colony formation, as shown by low A numbers. In fact, in two cases (1 l .2% and 13% HbF) the effect of C M seemed to be inhibitory.
Correlation between absolute HbF and anemia in the patients studied. The regression line between peripheral HbF (expressed as absolute HbF g/dL) and H b levels had an r = .41 ( P -= .017).
DISCUSSION
It is generally believed that human BFU-E are not sensitive to 'H-TdR kill and thus not engaged in DNA synthesis, a conclusion based on experiments in which the proportion of BFU-E in DNA synthesis was determined by the cell suicide method in normal bone peripheral and peripheral blood of three patients with SS anemia* whose HbF level was not reported. It has been previously suggested that the number and proliferation of BFU-E are not influenced by anemia or hypoxia, states producing elevation in erythropoietin levels.9-" However, in a mouse model, Axelrad et all2 reported that bone marrow BFU-E may be recruited to proliferate under conditions of major hematopoietic stress produced by repeated bleeding.
Evidence is presented here that the increased number of circulating BFU-E in the patients with low peripheral HbF is associated with active cycling of BFU-E, while the BFU-E of patients with high HbF exhibited low sensitivity to 'H-TdR kill. Thus the higher number of circulating BFU-E in SS patients with low HbF may result from active proliferation of these progenitor cells. However, no information is available yet as to whether cycling of BFU-E is restricted only to the population of circulating BFU-E or whether amplification originates in the bone marrow compartments, leading to the increased exit of these cells to the blood stream.
Regression analysis was performed on data from 14 experiments in which the erythroid colonies were generated in the presence of 1.5 U EpO. The results showed that the percent of BFU-E kill was strongly and inversely correlated with the percent of peripheral H b F level of the same patient (P i .00003). Thus, HbF level appears also to be a sensitive indicator as to whether or not circulating BFU-E will be vulnerable to 'H-TdR kill and hence, proliferating.
The experiments reported here confirm the production of BPA-like factors by LD cells of SS patients and, in addition, they indicate that the production of this component is related to the peripheral level of HbF. BPA-like activity was detected in variable concentrations only in C M from patients with H b F levels lower than 9% (Mean A = 46.4 24.9). The C M conditioned by LD cells of SS patients with H b F higher than 9% has no detectable BPA-like activity, as shown by the lack of enhancing effect on erythroid colony formation (Mean A = 4.69 5 4.9).
The fact that BPA-like activity can be detected in the subpopulation of SS patients who exhibit an active cycling of BFU-E when LD cells are plated suggests that BPA-like activity may be implicated in the regulation of BFU-E proliferation of these patients.
Another argument in favor of the hypothesis that BFU-E proliferation is related to BPA production in this system is Based on these observations, we conclude that circulating erythroid progenitors of patients with high HbF levels and low HbF are quantitatively and qualitatively different populations.
As to what hemolymphopoietic growth factors might be the active components of the BPA-activity described here, we can only speculate. Most of the active factors present in BPA have been defined and characterized, and some have been c10ned.l~ Our working hypothesis is that the factor(s) responsible for the BPA-like activity in our system probably is granulocyte-macrophage colony-stimulating factor (GM-CSF) and/or interleukin-3 (IL-3). The observation of Suda et all4 that IL-3 is necessary for continued proliferation of hematopoietic progenitor cells supports this hypothesis. The mechanism by which the level of peripheral HbF is related to the type of BFU-E circulating is an intriguing question. One possibility is that SS patients genetically determined to have low HbF levels might maintain a particularly high steady-state erythropoiesis by activation of an emergency regulatory pathway in addition to one normally controlled by erythropoietin. Under these circumstances, increased BPA production leads to the amplification of erythroid compartments by proliferation of BPA-responsive progenitor cells.
Alternatively, high and low levels of peripheral HbF in sickle cell disease could be the consequence, and not the cause, of BFU-E heterogeneity. Work is underway in our laboratory to distinguish between these possibilities and to characterize the specific growth factors involved in this phenomenon.
